Intrauterine growth restriction (IUGR) continues to be an important cause of perinatal mortality and morbidity in modern obstetric. Physical evidence of abnormal fetal growth becomes typically apparent in the second half of pregnancy, although studies have suggested that indicators of aberrant growth may be present as early as in the first trimester. The ability to predict subsequent abnormal fetal growth in the first trimester could enable more appropriate fetal surveillance and management, which potentially might reduce perinatal complications due to fetal growth abnormalities.